Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1988 Oct 29;297(6656):1086–1091. doi: 10.1136/bmj.297.6656.1086

Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.

H H Parving 1, E Hommel 1, U M Smidt 1
PMCID: PMC1834890  PMID: 3143437

Abstract

STUDY OBJECTIVE--To assess whether long term inhibition of angiotensin converting enzyme with captopril and frusemide or bendrofluazide protects kidney function in diabetic nephropathy. DESIGN--Non-randomised controlled before-after trial of matched hypertensive insulin dependent diabetics with nephropathy treated with captopril and frusemide or bendrofluazide. SETTING--Outpatient diabetic clinic in tertiary referral centre. PATIENTS--Treatment group of 18 hypertensive insulin dependent diabetics with nephropathy (mean age 33), who had not been treated previously. Control group of 13 patients (mean age 32) fulfilling the same entry criteria from a prospective study. INTERVENTIONS--Treatment group was given daily captopril 37.5-100.0 mg and frusemide (mean) 98 mg (10 patients) or bendrofluazide (mean) 4 mg (seven). Treatment was continued for about two and a half years. Controls were not treated. END POINT--Measurement of arterial blood pressure, albuminuria, and glomerular filtration. MEASUREMENTS AND MAIN RESULTS--Baseline values were identical in treated and untreated groups respectively: mean blood pressure 146/93 (SE 3/1) mm Hg v 137/95 (2/1) mm Hg; geometric mean albuminuria 982 (antilog SE 1.2) micrograms/min v 936 (1.2) micrograms/min; and mean glomerular filtration rate 98 (SE 5) ml/min/1.73 m2 v 96 (6) ml/min/1.73 m2. Mean arterial blood pressure fell by 8.7 (1.3) mm Hg with captopril and rose by 6.6 (1.5) mm Hg in controls, (p less than 0.001); Albumin excretion decreased to 390 (1.1) micrograms/min with captopril and rose to 1367 (1.3) micrograms/min in controls (p less than 0.001). The rate of decrease in glomerular filtration rate was lower with captopril (5.8 (0.7) ml/year v 10.0 (1.3) ml/year) (p less than 0.01). Rate of fall in glomerular filtration rate and mean arterial blood pressure were significantly correlated (n = 31, r = 0.37, p less than 0.05). CONCLUSIONS--Captopril is a valuable new drug for treating hypertension in insulin dependent diabetics with nephropathy.

Full text

PDF
1086

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen A. R., Christiansen J. S., Andersen J. K., Kreiner S., Deckert T. Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia. 1983 Dec;25(6):496–501. doi: 10.1007/BF00284458. [DOI] [PubMed] [Google Scholar]
  2. Anderson S., Rennke H. G., Brenner B. M. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest. 1986 Jun;77(6):1993–2000. doi: 10.1172/JCI112528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bank N., Klose R., Aynedjian H. S., Nguyen D., Sablay L. B. Evidence against increased glomerular pressure initiating diabetic nephropathy. Kidney Int. 1987 Apr;31(4):898–905. doi: 10.1038/ki.1987.83. [DOI] [PubMed] [Google Scholar]
  4. Barnett A. H., Leslie D., Watkins P. J. Can insulin-treated diabetics be given beta-adrenergic blocking drugs? Br Med J. 1980 Apr 5;280(6219):976–978. doi: 10.1136/bmj.280.6219.976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bohrer M. P., Deen W. M., Robertson C. R., Brenner B. M. Mechanism of angiotensin II-induced proteinuria in the rat. Am J Physiol. 1977 Jul;233(1):F13–F21. doi: 10.1152/ajprenal.1977.233.1.F13. [DOI] [PubMed] [Google Scholar]
  6. Borch-Johnsen K., Andersen P. K., Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1985 Aug;28(8):590–596. doi: 10.1007/BF00281993. [DOI] [PubMed] [Google Scholar]
  7. Brenner B. M. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int. 1983 Apr;23(4):647–655. doi: 10.1038/ki.1983.72. [DOI] [PubMed] [Google Scholar]
  8. Bröchner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest. 1972 Nov;30(3):271–274. doi: 10.3109/00365517209084290. [DOI] [PubMed] [Google Scholar]
  9. Cohen D., Dodds R., Viberti G. Effect of protein restriction in insulin dependent diabetics at risk of nephropathy. Br Med J (Clin Res Ed) 1987 Mar 28;294(6575):795–798. doi: 10.1136/bmj.294.6575.795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Croog S. H., Levine S., Testa M. A., Brown B., Bulpitt C. J., Jenkins C. D., Klerman G. L., Williams G. H. The effects of antihypertensive therapy on the quality of life. N Engl J Med. 1986 Jun 26;314(26):1657–1664. doi: 10.1056/NEJM198606263142602. [DOI] [PubMed] [Google Scholar]
  11. Deckert T., Poulsen J. E., Larsen M. Prognosis of diabetics with diabetes onset before the age of thirty-one. I. Survival, causes of death, and complications. Diabetologia. 1978 Jun;14(6):363–370. doi: 10.1007/BF01228130. [DOI] [PubMed] [Google Scholar]
  12. Feldt-Rasmussen B., Mathiesen E. R., Deckert T., Giese J., Christensen N. J., Bent-Hansen L., Nielsen M. D. Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1987 Aug;30(8):610–617. doi: 10.1007/BF00277316. [DOI] [PubMed] [Google Scholar]
  13. Heeg J. E., de Jong P. E., van der Hem G. K., de Zeeuw D. Reduction of proteinuria by angiotensin converting enzyme inhibition. Kidney Int. 1987 Jul;32(1):78–83. doi: 10.1038/ki.1987.174. [DOI] [PubMed] [Google Scholar]
  14. Hommel E., Parving H. H., Mathiesen E., Edsberg B., Damkjaer Nielsen M., Giese J. Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J (Clin Res Ed) 1986 Aug 23;293(6545):467–470. doi: 10.1136/bmj.293.6545.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hostetter T. H., Rennke H. G., Brenner B. M. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med. 1982 Mar;72(3):375–380. doi: 10.1016/0002-9343(82)90490-9. [DOI] [PubMed] [Google Scholar]
  16. Hostetter T. H., Troy J. L., Brenner B. M. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int. 1981 Mar;19(3):410–415. doi: 10.1038/ki.1981.33. [DOI] [PubMed] [Google Scholar]
  17. Ichikawa I., Brenner B. M. Glomerular actions of angiotensin II. Am J Med. 1984 May 31;76(5B):43–49. doi: 10.1016/0002-9343(84)90882-9. [DOI] [PubMed] [Google Scholar]
  18. Isaksson B. Urinary nitrogen output as a validity test in dietary surveys. Am J Clin Nutr. 1980 Jan;33(1):4–5. doi: 10.1093/ajcn/33.1.4. [DOI] [PubMed] [Google Scholar]
  19. Jensen P. K., Steven K., Blaehr H., Christiansen J. S., Parving H. H. Effects of indomethacin on glomerular hemodynamics in experimental diabetes. Kidney Int. 1986 Feb;29(2):490–495. doi: 10.1038/ki.1986.26. [DOI] [PubMed] [Google Scholar]
  20. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  21. Maroni B. J., Steinman T. I., Mitch W. E. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int. 1985 Jan;27(1):58–65. doi: 10.1038/ki.1985.10. [DOI] [PubMed] [Google Scholar]
  22. Marre M., Leblanc H., Suarez L., Guyenne T. T., Ménard J., Passa P. Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. Br Med J (Clin Res Ed) 1987 Jun 6;294(6585):1448–1452. doi: 10.1136/bmj.294.6585.1448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mauer S. M., Steffes M. W., Azar S., Sandberg S. K., Brown D. M. The effects of Goldblatt hypertension on development of the glomerular lesions of diabetes mellitus in the rat. Diabetes. 1978 Jul;27(7):738–744. doi: 10.2337/diab.27.7.738. [DOI] [PubMed] [Google Scholar]
  24. Miles D. W., Mogensen C. E., Gundersen H. J. Radioimmunoassay for urinary albumin using a single antibody. Scand J Clin Lab Invest. 1970 Aug;26(1):5–11. doi: 10.3109/00365517009049206. [DOI] [PubMed] [Google Scholar]
  25. Mogensen C. E. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J (Clin Res Ed) 1982 Sep 11;285(6343):685–688. doi: 10.1136/bmj.285.6343.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Mortensen H. B. Quantitative determination of hemoglobin A1c by thin-layer isoelectric focusing. J Chromatogr. 1980 Jun 13;182(3-4):325–333. doi: 10.1016/s0378-4347(00)81481-4. [DOI] [PubMed] [Google Scholar]
  27. Myers B. D., Deen W. M., Brenner B. M. Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat. Circ Res. 1975 Jul;37(1):101–110. doi: 10.1161/01.res.37.1.101. [DOI] [PubMed] [Google Scholar]
  28. Nyberg G., Nordén G., Attman P. O., Aurell M., Uddebom G., Lenner R. A., Isaksson B. Diabetic nephropathy: is dietary protein harmful? J Diabet Complications. 1987 Apr-Jun;1(2):37–40. doi: 10.1016/s0891-6632(87)80077-6. [DOI] [PubMed] [Google Scholar]
  29. Parving H. H., Andersen A. R., Smidt U. M., Christiansen J. S., Oxenbøll B., Svendsen P. A. Diabetic nephropathy and arterial hypertension. The effect of antihypertensive treatment. Diabetes. 1983 May;32 (Suppl 2):83–87. doi: 10.2337/diab.32.2.s83. [DOI] [PubMed] [Google Scholar]
  30. Parving H. H., Andersen A. R., Smidt U. M., Hommel E., Mathiesen E. R., Svendsen P. A. Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J (Clin Res Ed) 1987 Jun 6;294(6585):1443–1447. doi: 10.1136/bmj.294.6585.1443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Parving H. H., Andersen A. R., Smidt U. M., Oxenbøll B., Edsberg B., Christiansen J. S. Diabetic nephropathy and arterial hypertension. Diabetologia. 1983 Jan;24(1):10–12. doi: 10.1007/BF00275939. [DOI] [PubMed] [Google Scholar]
  32. Parving H. H., Hommel E., Mathiesen E., Skøtt P., Edsberg B., Bahnsen M., Lauritzen M., Hougaard P., Lauritzen E. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J (Clin Res Ed) 1988 Jan 16;296(6616):156–160. doi: 10.1136/bmj.296.6616.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Parving H. H., Kastrup H., Smidt U. M., Andersen A. R., Feldt-Rasmussen B., Christiansen J. S. Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia. 1984 Dec;27(6):547–552. doi: 10.1007/BF00276965. [DOI] [PubMed] [Google Scholar]
  34. Parving H. H., Viberti G. C., Keen H., Christiansen J. S., Lassen N. A. Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism. 1983 Sep;32(9):943–949. doi: 10.1016/0026-0495(83)90210-x. [DOI] [PubMed] [Google Scholar]
  35. Paulson O. B., Jarden J. O., Vorstrup S., Holm S., Godtfredsen J. Effect of captopril on the cerebral circulation in chronic heart failure. Eur J Clin Invest. 1986 Apr;16(2):124–132. doi: 10.1111/j.1365-2362.1986.tb01319.x. [DOI] [PubMed] [Google Scholar]
  36. Puska P., Iacono J. M., Nissinen A., Korhonen H. J., Vartianinen E., Pietinen P., Dougherty R., Leino U., Mutanen M., Moisio S. Controlled, randomised trial of the effect of dietary fat on blood pressure. Lancet. 1983 Jan 1;1(8314-5):1–5. doi: 10.1016/s0140-6736(83)91556-8. [DOI] [PubMed] [Google Scholar]
  37. Roberts D. H., Tsao Y., McLoughlin G. A., Breckenridge A. Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication. Lancet. 1987 Sep 19;2(8560):650–653. doi: 10.1016/s0140-6736(87)92441-x. [DOI] [PubMed] [Google Scholar]
  38. Viberti G. C., Bilous R. W., Mackintosh D., Keen H. Monitoring glomerular function in diabetic nephropathy. A prospective study. Am J Med. 1983 Feb;74(2):256–264. doi: 10.1016/0002-9343(83)90624-1. [DOI] [PubMed] [Google Scholar]
  39. Zatz R., Dunn B. R., Meyer T. W., Anderson S., Rennke H. G., Brenner B. M. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest. 1986 Jun;77(6):1925–1930. doi: 10.1172/JCI112521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Zeng Y. T., Huang S. Z. Alpha-globin gene organisation and prenatal diagnosis of alpha-thalassaemia in Chinese. Lancet. 1985 Feb 9;1(8424):304–307. doi: 10.1016/s0140-6736(85)91081-5. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES